Buy BioXcel Therapeutics Stock | BTAI Stock Price & Latest News | Public
BTAI

BioXcel Therapeutics

$0.00 (0.00%)Today

    About BTAI

    BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on drug development. The firm's two clinical development programs are BXCL501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurologica...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.35
    -0.71
    -1.06
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.80

    Actual EPS
    Q3 2020

    Stats

    Market Cap$1,08B
    Volume34,94k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$71.50
    1 Year Low$3.76
    Open$48.48
    High$49.24
    Low$47.63

    Buy any stock with any amount of money.

    Download the App
    Download the app